168 related articles for article (PubMed ID: 3652475)
1. Comparison of intestinal calcium absorption and circulating 1,25-dihydroxyvitamin D levels in malignancy-associated hypercalcaemia and primary hyperparathyroidism.
Ralston SH; Cowan RA; Gardner MD; Fraser WD; Marshall E; Boyle IT
Clin Endocrinol (Oxf); 1987 Mar; 26(3):281-91. PubMed ID: 3652475
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium.
Ralston SH; Fogelman I; Gardner MD; Dryburgh FJ; Cowan RA; Boyle IT
Clin Sci (Lond); 1984 Feb; 66(2):187-91. PubMed ID: 6692653
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. New insights on the pathogenesis of hypercalcemia in primary hyperparathyroidism.
Yonemura K; Suzuki H; Fujigaki Y; Hishida A
Am J Med Sci; 2000 Nov; 320(5):334-6. PubMed ID: 11093687
[TBL] [Abstract][Full Text] [Related]
5. Influence of urinary sodium excretion on the clinical assessment of renal tubular calcium reabsorption in hypercalcaemic man.
Ralston SH; Gardner MD; Dryburgh FJ; Cowan RA; Boyle IT
J Clin Pathol; 1986 Jun; 39(6):641-6. PubMed ID: 3722417
[TBL] [Abstract][Full Text] [Related]
6. Effect of parathyroidectomy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in primary hyperparathyroidism.
Bone HG; Zerwekh JE; Haussler MR; Pak CY
J Clin Endocrinol Metab; 1979 May; 48(5):877-9. PubMed ID: 429532
[TBL] [Abstract][Full Text] [Related]
7. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
[TBL] [Abstract][Full Text] [Related]
8. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
[TBL] [Abstract][Full Text] [Related]
9. Familial benign hypercalcaemia. Study of a large family.
Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G
Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672
[TBL] [Abstract][Full Text] [Related]
10. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium.
Gardin JP; Paillard M
Miner Electrolyte Metab; 1984; 10(5):301-8. PubMed ID: 6493158
[TBL] [Abstract][Full Text] [Related]
11. Clinical studies on phosphate handling in hypercalcaemia.
Wikström B; Ljunghall S; Wide L; Akerström G
Acta Med Scand; 1982; 212(6):413-20. PubMed ID: 6297262
[TBL] [Abstract][Full Text] [Related]
12. Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism.
Harvey JA; Zerwekh JE; Sakhaee K; Pak CY
J Clin Endocrinol Metab; 1989 Aug; 69(2):467-9. PubMed ID: 2787802
[TBL] [Abstract][Full Text] [Related]
13. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism.
Broadus AE; Horst RL; Lang R; Littledike ET; Rasmussen H
N Engl J Med; 1980 Feb; 302(8):421-6. PubMed ID: 7351950
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
[TBL] [Abstract][Full Text] [Related]
15. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH.
Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T
Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets.
Kruse K
J Pediatr; 1995 May; 126(5 Pt 1):736-41. PubMed ID: 7751997
[TBL] [Abstract][Full Text] [Related]
17. Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia.
Nakayama K; Fukumoto S; Takeda S; Takeuchi Y; Ishikawa T; Miura M; Hata K; Hane M; Tamura Y; Tanaka Y; Kitaoka M; Obara T; Ogata E; Matsumoto T
J Clin Endocrinol Metab; 1996 Feb; 81(2):607-11. PubMed ID: 8636276
[TBL] [Abstract][Full Text] [Related]
18. Tubular calcium reabsorption and other aspects of calcium homeostasis in primary and secondary hyperparathyroidism.
Phelps KR; Stote KS; Mason D
Clin Nephrol; 2014 Aug; 82(2):83-91. PubMed ID: 24985952
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
[TBL] [Abstract][Full Text] [Related]
20. Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour.
Ralston SH; Boyce BF; Cowan RA; Gardner MD; Dryburgh FJ; Boyle IT
Q J Med; 1986 Mar; 58(227):325-35. PubMed ID: 3016790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
